Oncology: Squamous cell carcinoma of the esophagus: Evaluation of the status of epidermal growth factor receptors (EGFR and HER-2) by immunohistochemistry and in situ hybridization

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 5, 2010, Pages 615-620

  Delektorskaya, V V ^a   Chemeris, G Yu ^a   Zavalishina, L E ^b   Ryazantseva, A A ^b   Grigorchuk, A Yu ^a   Kononets, P V ^a   Davydov, M I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Federal Agency for High Technological Medical Care   (Russian Federation)

Author keywords

Carcinoma of the esophagus; EGFR; Fluorescent in situ hybridization; HER 2; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; ANEUPLOIDY; BIOSYNTHESIS; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANEUPLOIDY; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 7; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 79951636225     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-1007-z     Document Type: Article

References (15)

1. V. V. Delektorskaya, G. Yu. Chemeris, P. V. Kononets, and A. Yu. Grigorchuk, Byull. Eksp. Biol. Med., 148, No. 8, 213-218 (2009)
2. M. Akamatsu, T. Matsumoto, K. Oka, et al., Int. J. Radiat. Oncol. Biol. Phys., 57, 1323-282 (2003).
3. M. Dreilich, A. Wanders, D. Brattström, et al., Dis. Esophagus., 19, No. 4, 224-231 (2006).
4. L. Gibault, J. P. Metges, V. Conan-Charlet, et al., Br. J. Cancer, 93, 107-115 (2005).
5. I. Gockel, M. Moehler, K. Frerichs, et al., Oncol. Rep., 20, No. 4, 845-850 (2008).
6. M. Gotoh, H. Takiuchi, S. Kawabe, et al., Jpn. J. Clin. Oncol., Vol. 37, No. 9, 652-657 (2007).
7. M. Hanawa, S. Suzuki, Y. Dobashi, et al., Int. J. Cancer., 118, 1173-1180 (2006).
8. Z. Liang, X. Zeng, J. Gao, BMC Cancer, 8, 363 (2008).
9. D. C. Lin, X. L. Du, M. R. Wang, Dis. Esophagus., 22, No. 1, 9-20 (2009).
10. K. Mimura, K. Kono M., Hanawa, et al., Br. J. Cancer, 92, 1253-1260 (2005).
11. S. Morgan and J. R .Grandis, Exp. Cell Res., 315, No. 4, 572-582 (2009).
12. U. Reichelt, P. Duesedau, M. Tsourlakis, et al., Mod. Pathol., 20, 120-129 (2007).
13. I. Rubin and Y. Yarden, Ann. Oncol., 12, Suppl. 1, S3-S8 (2001).
14. Y. Sato-Kuwabara, J. I. Neves, J. H. Fregnani, et al., BMC Cancer., 9, 6 (2009).
15. P. Sunpaweravong, S. Sunpaweravong, P. Puttawibul, et al., J. Cancer Res. Clin. Oncol., 131, 111-119 (2005).